Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

AngioDynamics Inc (ANGO) USD0.01

Sell:$24.39 Buy:$24.42 Change: $0.18 (0.74%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.18 (0.74%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.18 (0.74%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Vascular Interventions & Therapies, Vascular Access and Oncology. The Company's Vascular Interventions & Therapies products include Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines. Through its subsidiary, Eximo Medical, Ltd., the Company operates 355 nanometers (nm) wavelength laser-technology platform.

Contact details

14 Plaza Dr
United States
+1 (518) 7981215

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$921.12 million
Shares in issue:
38.44 million
Health Care Equipment
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Howard Donnelly
    Independent Chairman of the Board
  • James Clemmer
    President, Chief Executive Officer, Director
  • Stephen Trowbridge
    Chief Financial Officer, Executive Vice President
  • Richard Rosenzweig
    Senior Vice President, General Counsel, Company Secretary
  • Brent Boucher
    Senior Vice President and General Manager, Oncology/Surgery
  • Chad Campbell
    Senior Vice President and General Manager, Vascular Access
  • Scott Centea
    Senior Vice President, General Manager, VIT
  • Marna Bronfen-Moore
    Senior Vice President of Human Resources
  • Benjamin Davis
    Senior Vice President Business Development
  • David Helsel
    Senior Vice President - Global Operations

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.